Conditioning regimens used in 183 RIC allogeneic transplantations with or without lymphocyte-depleting antibodies
Drug combination . | No. of Abs . | ATG . | Alemtuzumab . | Total . |
|---|---|---|---|---|
| Fd + busulfan | 12 | 75 | 8 | 95 |
| Cyclophosphamide + thiotepa | 17 | 1 | 0 | 18 |
| Fd + TBI | 14 | 2 | 0 | 16 |
| Fd + melphalan + cyclophosphamide | 2 | 5 | 5 | 12 |
| Fd + melphalan | 0 | 5 | 5 | 10 |
| Fd + cyclophosphamide | 5 | 1 | 2 | 8 |
| Other | 4 | 3 | 0 | 8 |
| Fd + busulfan + Other | 2 | 4 | 1 | 7 |
| Busulfan ± other | 2 | 3 | 0 | 5 |
| Fd ± cytarabine | 0 | 4 | 0 | 4 |
| Cyclophosphamide | 0 | 3 | 0 | 3 |
Drug combination . | No. of Abs . | ATG . | Alemtuzumab . | Total . |
|---|---|---|---|---|
| Fd + busulfan | 12 | 75 | 8 | 95 |
| Cyclophosphamide + thiotepa | 17 | 1 | 0 | 18 |
| Fd + TBI | 14 | 2 | 0 | 16 |
| Fd + melphalan + cyclophosphamide | 2 | 5 | 5 | 12 |
| Fd + melphalan | 0 | 5 | 5 | 10 |
| Fd + cyclophosphamide | 5 | 1 | 2 | 8 |
| Other | 4 | 3 | 0 | 8 |
| Fd + busulfan + Other | 2 | 4 | 1 | 7 |
| Busulfan ± other | 2 | 3 | 0 | 5 |
| Fd ± cytarabine | 0 | 4 | 0 | 4 |
| Cyclophosphamide | 0 | 3 | 0 | 3 |
Abs indicates antibodies; ATG, antithymocyte globulin; Fd, fludarabine; TBI, total body irradiation.